Dr. Ding is a professor of Cell Biology and holds the Joanne I. Moore Professorship of Pharmacology at the University of Oklahoma Health Sciences Center. She obtained her PhD from the University of Lund (Sweden) and received post-doctoral training at the Mayo Clinic and Foundation, MN. The primary focus of Dr. Ding’s laboratory research is to understand the mechanism(s) of retinal degeneration in order to identify novel therapeutic strategies. Dr. Ding has published over 50 research articles in peer-reviewed journals, and her research has been supported by the National Institute of Health, the Foundation Fighting Blindness, and the Oklahoma Center for Advancement in Science and Technology, in addition to BrightFocus Foundation.
Xi-Qin Ding, PhD
First published on: August 10, 2018
Last modified on: December 22, 2024